Reblozyl 25 MG Injection

RxCUI: 2262911
RxNorm name: Reblozyl 25 MG Injection
Display name: Reblozyl 25 MG Injection
Full name: Reblozyl 25 MG Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:06

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761136	Reblozyl	luspatercept-aamt	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Reblozyl	LUSPATERCEPT	Celgene Corporation	82f4d266-3f52-41eb-86ba-0abf3cf468e8	2026-02-27	Warnings, Adverse reactions	Exact identifier rxcui: 2262911

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
82f4d266-3f52-41eb-86ba-0abf3cf468e8	Reblozyl 25 MG Injection	PSN	20	These highlights do not include all the information needed to use REBLOZYL safely and effectively. See full prescribing information for REBLOZYL. REBLOZYL ® (luspatercept-aamt) for injection, for subcutaneous use Initial U.S. Approval: 2019	20260227
82f4d266-3f52-41eb-86ba-0abf3cf468e8	Reblozyl 25 MG Injection	SY	20	These highlights do not include all the information needed to use REBLOZYL safely and effectively. See full prescribing information for REBLOZYL. REBLOZYL ® (luspatercept-aamt) for injection, for subcutaneous use Initial U.S. Approval: 2019	20260227
82f4d266-3f52-41eb-86ba-0abf3cf468e8	luspatercept-aamt 25 MG Injection [Reblozyl]	SBD	20	These highlights do not include all the information needed to use REBLOZYL safely and effectively. See full prescribing information for REBLOZYL. REBLOZYL ® (luspatercept-aamt) for injection, for subcutaneous use Initial U.S. Approval: 2019	20260227